98 related articles for article (PubMed ID: 28067383)
21. MicroRNA expression profiles in serous ovarian carcinoma.
Nam EJ; Yoon H; Kim SW; Kim H; Kim YT; Kim JH; Kim JW; Kim S
Clin Cancer Res; 2008 May; 14(9):2690-5. PubMed ID: 18451233
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
[TBL] [Abstract][Full Text] [Related]
23. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.
van Jaarsveld MT; Helleman J; Boersma AW; van Kuijk PF; van Ijcken WF; Despierre E; Vergote I; Mathijssen RH; Berns EM; Verweij J; Pothof J; Wiemer EA
Oncogene; 2013 Sep; 32(36):4284-93. PubMed ID: 23045278
[TBL] [Abstract][Full Text] [Related]
24. A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.
Wang X; Wang SS; Zhou L; Yu L; Zhang LM
J Ovarian Res; 2016 Nov; 9(1):73. PubMed ID: 27806724
[TBL] [Abstract][Full Text] [Related]
25. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
26. Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients.
Penyige A; Márton É; Soltész B; Szilágyi-Bónizs M; Póka R; Lukács J; Széles L; Nagy B
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540229
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA and transcription factor mediated regulatory network analysis reveals critical regulators and regulatory modules in myocardial infarction.
Zhang G; Shi H; Wang L; Zhou M; Wang Z; Liu X; Cheng L; Li W; Li X
PLoS One; 2015; 10(8):e0135339. PubMed ID: 26258537
[TBL] [Abstract][Full Text] [Related]
28. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
Hirata Y; Murai N; Yanaihara N; Saito M; Saito M; Urashima M; Murakami Y; Matsufuji S; Okamoto A
BMC Cancer; 2014 Nov; 14():799. PubMed ID: 25366985
[TBL] [Abstract][Full Text] [Related]
30. Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome.
Du J; Zhang L
Oncol Rep; 2015 Aug; 34(2):585-94. PubMed ID: 26035298
[TBL] [Abstract][Full Text] [Related]
31. MIR-142-5p and miR-9 may be involved in squamous lung cancer by regulating cell cycle related genes.
Su YH; Zhou Z; Yang KP; Wang XG; Zhu Y; Fa XE
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(23):3213-20. PubMed ID: 24338464
[TBL] [Abstract][Full Text] [Related]
32. Survival-related profile, pathways, and transcription factors in ovarian cancer.
Crijns AP; Fehrmann RS; de Jong S; Gerbens F; Meersma GJ; Klip HG; Hollema H; Hofstra RM; te Meerman GJ; de Vries EG; van der Zee AG
PLoS Med; 2009 Feb; 6(2):e24. PubMed ID: 19192944
[TBL] [Abstract][Full Text] [Related]
33. The shaping and functional consequences of the dosage effect landscape in multiple myeloma.
Samur MK; Shah PK; Wang X; Minvielle S; Magrangeas F; Avet-Loiseau H; Munshi NC; Li C
BMC Genomics; 2013 Oct; 14():672. PubMed ID: 24088394
[TBL] [Abstract][Full Text] [Related]
34. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
35. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
[TBL] [Abstract][Full Text] [Related]
37. Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer.
Zhu J; Chen Z; Yong L
Gynecol Oncol; 2018 Feb; 148(2):368-374. PubMed ID: 29191436
[TBL] [Abstract][Full Text] [Related]
38. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
39. Construction of a lncRNA-mediated feed-forward loop network reveals global topological features and prognostic motifs in human cancers.
Ning S; Gao Y; Wang P; Li X; Zhi H; Zhang Y; Liu Y; Zhang J; Guo M; Han D; Li X
Oncotarget; 2016 Jul; 7(29):45937-45947. PubMed ID: 27322142
[TBL] [Abstract][Full Text] [Related]
40. A prognostic 11 genes expression model for ovarian cancer.
Men CD; Liu QN; Ren Q
J Cell Biochem; 2018 Feb; 119(2):1971-1978. PubMed ID: 28817186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
